Eddingpharm
Eddingpharm's email is publicrelations@eddingpharm.com
and
Eddingpharm's phone number is +852 37550555
.
Established in 2001, Eddingpharm’s vision and mission has always been to become China's leading supplier of patented drugs and branded drugs, bridge the gap between Chinese patients and global high quality medicines. They constantly acquired classic branded medicines from MNCs, that benefits Chinese patients through our effective operation cost management and expansion to the low-tier medical terminals. On the other hand, they keep exploring and innovating. Eddingpharm continuously introduce abroad patented drugs to China market, participate in international multi-center...
read more
Established in 2001, Eddingpharm’s vision and mission has always been to become China's leading supplier of patented drugs and branded drugs, bridge the gap between Chinese patients and global high quality medicines. They constantly acquired classic branded medicines from MNCs, that benefits Chinese patients through our effective operation cost management and expansion to the low-tier medical terminals. On the other hand, they keep exploring and innovating. Eddingpharm continuously introduce abroad patented drugs to China market, participate in international multi-center clinical trials and strive to realize simultaneous launch of new drugs in China and globally, providing physicians with more treatment options. Over the past few years, they rapidly expanded our business and strategically deployed resources in various fields. They are upgrading to a whole-industry-chain entity from sole in-licensing R&D and commercialization. Eddingpharm has nearly 1,000 professional representatives in 30 provinces across the country, with coverage of 19,000+ hospitals and 20,000+ pharmacies. Over the years, they have collaborated with multinational pharmaceutical companies, specialty pharmaceutical companies and leading R&D institutions to enrich our product portfolio by in-licensing patented drugs, setting up JV, gaining exclusive distribution rights and forming strategic alliances. Our focused therapy areas have been expanded to anti-biology, oncology, respiratory, cardiovascular and renal diseases. In addition, our several new drugs under development or regulatory registration are expected to be launched in the near future. The revolutionary product Vascepa® capsule is a single-molecule prescription product consisting of the icosapentaenoic acid commonly known as EPA in ethyl-ester form. Its ability has been verified that lowering triglyceride levels in relevant patient populations without raising LDL-cholesterol levels. The ability of reducing residual cardiovascular risk in patients with statin-managed LDL-C cholesterol, but persistent elevated triglycerides, has been published in The New England Journal of Medicine in November 2018. Additional results and analysis of total recurrent events observed were subsequently published in the Journal of American College of Cardiology in March 2019. Recently, supplemental new drug application (sNDA) for Vascepa® capsules reducing cardiovascular risks has been accepted for filing and granted Priority Review designation by the US FDA. Eddingpharm has been granted the rights of development, commercialization and supply of VASCEPA® in mainland China, Hong Kong, Macau and Taiwan since 2015, also including the management and sponsor of pivotal clinical trials for registration. They have completed a pharmacokinetic (PK) study in China and a racial comparison study of PK characteristics between Chinese and American healthy subjects. Phase III clinical trial is currently in progress. ''Professionalism, excellence, responsibility, and persistence'' are the values of Eddingpharm. Our profession is related to life and health, professionalism is the fundamental principle. Excellence runs through every minute of our work. Responsibility is our attitude towards each task. In the face of our beliefs and missions, they will stick to persistence and never give up. They are moving towards the goal that Chinese patients benefit from the world's best medicines and cutting edge medical technology.
show less
Website | eddingpharm.com | |
Industry | Pharmaceuticals | |
Location | Hong Kong | |
Employees | 188 | |
Founded | 2001 |
HQ | Suite 3306, 33rd Floor,Tower 6 The Gateway Harbour City Kowloon | |
Phone | +852 3-755-0555 | |
publicrelations@eddingpharm.com | ||
Funding | 44,058,233 USD | |
Competitors | Walgreens Boots Allia..., Pfizer, Cvs Health, Novartis, Gsk, Bayer, |
Website | eddingpharm.com | |
Industry | Pharmaceuticals | |
Location | Hong Kong | |
Employees | 188 | |
Founded | 2001 | |
linkedin.com/company/eddingpharm | ||
HQ | Suite 3306, 33rd Floor,Tower 6 The Gateway Harbour City Kowloon | |
Phone | +852 3-755-0555 | |
publicrelations@eddingpharm.com | ||
Funding | 44,058,233 USD |
Email Patterns for Eddingpharm
Top Competitors for Eddingpharm
Eddingpharm Questions
Where are Eddingpharm's headquarters?
Eddingpharm's headquarters are in Suite 3306, 33rd Floor,Tower 6 The Gateway Harbour City Kowloon
What is Eddingpharm's phone number?
Eddingpharm's phone number is +852 37550555
What is Eddingpharm's official website?
Eddingpharm's website is eddingpharm.com
How many employees are working in Eddingpharm right now?
Eddingpharm has
188 employees.
View the Email and Phone Numbers for all 188 working at Eddingpharm.
What is Eddingpharm's industry?
Eddingpharm's industry is
Pharmaceuticals
Who are Eddingpharm's top competitors?
Eddingpharm's top competitors are
Walgreens Boots Alliance
,
Pfizer
,
Cvs Health
,
Novartis
,
Gsk
,
Bayer
What is Eddingpharm's email address?
Eddingpharm's email address is publicrelations@eddingpharm.com
What are Eddingpharm's categories?
Eddingpharm's categories are Biotechnology, Clinical Trials, Health Care, Pharmaceutical
What is Eddingpharm's location?
Eddingpharm's location is
Hong Kong
When was Eddingpharm's founded?
Eddingpharm's founding year is 2001
What is Eddingpharm's funding?
Eddingpharm's funding is 44,058,233 USD
What is Eddingpharm's current status?
Eddingpharm's current status is operating
Top Eddingpharm Employees
Supply Chain Project Manager
charles@mtcindustries.com
+1352-214-7085
Vice President Of Operations
nicole.yu.zhiying@gmail.com
+1805-379-9880
Pv Supervisor
susan.yu@sanofi.com
招聘专家
Business And Crm Manager
cui.vitas@hisun-pfizer.com
Chief Marketing Officer Quality Senior Manager
Assistant Accountant
zzzaaf@gmail.com